Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure.

MLA

Sayour, Alex Ali, et al. “Characterization of Left Ventricular Myocardial Sodium-Glucose Cotransporter 1 Expression in Patients with End-Stage Heart Failure.” Cardiovascular Diabetology, vol. 19, no. 1, Sept. 2020, p. 159. EBSCOhost, https://doi.org/10.1186/s12933-020-01141-1.

APA

Sayour, A. A., Oláh, A., Ruppert, M., Barta, B. A., Horváth, E. M., Benke, K., Pólos, M., Hartyánszky, I., Merkely, B., & Radovits, T. (2020). Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure. Cardiovascular Diabetology, 19(1), 159. https://doi.org/10.1186/s12933-020-01141-1

Chicago

Sayour, Alex Ali, Attila Oláh, Mihály Ruppert, Bálint András Barta, Eszter Mária Horváth, Kálmán Benke, Miklós Pólos, István Hartyánszky, Béla Merkely, and Tamás Radovits. 2020. “Characterization of Left Ventricular Myocardial Sodium-Glucose Cotransporter 1 Expression in Patients with End-Stage Heart Failure.” Cardiovascular Diabetology 19 (1): 159. doi:10.1186/s12933-020-01141-1.